Prosensa (The Netherlands), an SME whose technology is at the forefront of developing a treatment for Duchenne Muscular Dystrophy (DMD) - a lethal childhood rare disease; and to-BBB (The Netherlands), who have discovered a new technology to enhance drug delivery across the bloodbrain barrier to treat medical conditions such as brain cancer, Alzheimer???s disease and multiple sclerosis.